Page 2586 - Hematology_ Basic Principles and Practice ( PDFDrive )

2303.e6 Part XIII Consultative Hematology

245. Leiby DA, Fucci MH, Stumpf RJ: Trypanosoma cruzi in a low- to 266. Ruebush TK, 2nd, Juranek DD, Chisholm ES, et al: Human babesiosis
moderate-risk blood donor population: seroprevalence and possible on Nantucket Island: evidence for self-limited and subclinical infec-
congenital transmission. Transfusion 39:310, 1999. tions. N Engl J Med 297:825, 1977.
246. Lane D, Sher G, Ward B: Investigation of the second case of transfusion 267. Benach JL, Habicht GS: Clinical characteristics of human babesiosis. J
transmitted Chagas disease in Canada [abstract]. Blood 96(11):60a, Infect Dis 144:481, 1981.
2000. 268. Ong KR, Stavropoulos C, Inada Y: Babesiosis, asplenia, and AIDS.
247. Appleman MD, Shulman IA, Saxena S, et al: Use of a questionnaire to Lancet 336:112, 1990.
identify potential blood donors at risk for infection with Trypanosoma 269. Falagas ME, Klempner MS: Babesiosis in patients with AIDS: a chronic
cruzi. Transfusion 33:61, 1993. infection presenting as fever of unknown origin. Clin Infect Dis 22:809,
248. Galel SA, Kirchhoff LV: Risk factors for Trypanosoma cruzi infection in 1996.
California blood donors. Transfusion 36:227, 1996. 270. Berry A, Morassin B, Kamar N, et al: Clinical picture: human babesio-
249. Leiby DA, Lenes BA, Tibbals MA, et al: Prospective evaluation of a sis. Lancet 357:341, 2001.
patient with Trypanosoma cruzi infection transmitted by transfusion. 271. Kjemtrup AM, Conrad PA: Human babesiosis: an emerging tick-borne
N Engl J Med 341:1237, 1999. disease. Int J Parasitol 30:1323, 2000.
250. Assal A, Corbi C: Chagas disease and blood transfusion: an emerging 272. Martinot M, Zadeh MM, Hansmann Y, et al: Babesiosis in immuno-
issue in non-endemic countries. Transfus Clin Biol 18:286, 2011. competent patients, Europe. Emerg Infect Dis 17:114, 2011.
251. Tobler LH, Contestable P, Pitina L, et al: Evaluation of a new enzyme- 273. Gulersen M, Brost BC, Bobrovnikov V, et al: Acute babesiosis in
linked immunosorbent assay for detection of Chagas antibody in US pregnancy: a novel imitator of hemolysis, elevated liver enzymes, and
blood donors. Transfusion 47:90, 2007. low platelet count syndrome. Obstet Gynecol 128:197, 2016.
252. Kirchhoff LV, Gam AA, Gusmao RA, et al: Increased specificity of 274. Uhnoo I, Cars O, Christensson D, et al: First documented case of
serodiagnosis of Chagas’ disease by detection of antibody to the 72- and human babesiosis in Sweden. Scand J Infect Dis 24:541, 1992.
90-kilodalton glycoproteins of Trypanosoma cruzi. J Infect Dis 155:561, 275. Sun T, Tenenbaum MJ, Greenspan J, et al: Morphologic and clinical
1987. observations in human infection with Babesia microti. J Infect Dis
253. Berrizbeitia M, Ndao M, Bubis J, et al: Purified excreted-secreted 148:239, 1983.
antigens from Trypanosoma cruzi trypomastigotes as tools for diagnosis 276. Hoare CA: Comparative aspects of human babesiosis. Trans R Soc Trop
of Chagas’ disease. J Clin Microbiol 44:291, 2006. Med Hyg 74:143, 1980.
254. Berrizbeitia M, Ndao M, Bubis J, et al: Field evaluation of four novel 277. Krause PJ, Telford SR, 3rd, Ryan R, et al: Diagnosis of babesiosis: evalu-
enzyme immunoassays for Chagas’ disease in Venezuela blood banks: ation of a serologic test for the detection of Babesia microti antibody. J
comparison of assays using fixed-epimastigotes, fixed-trypomastigotes Infect Dis 169:923, 1994.
or trypomastigote excreted-secreted antigens from two Trypanosoma 278. Wang G, Villafuerte P, Zhuge J, et al: Comparison of a quantitative
cruzi strains. Transfus Med 16:419, 2006. PCR assay with peripheral blood smear examination for detection and
255. Schofield CJ, Jannin J, Salvatella R: The future of Chagas disease quantitation of Babesia microti infection in humans. Diagn Microbiol
control. Trends Parasitol 22:583, 2006. Infect Dis 82:109, 2015.
256. Hunfeld KP, Hildebrandt A, Gray JS: Babesiosis: recent insights into 279. Rollend L, Bent SJ, Krause PJ, et al: Quantitative PCR for detection
an ancient disease. Int J Parasitol 38:1219, 2008. of Babesia microti in Ixodes scapularis ticks and in human blood. Vector
257. Vannier E, Krause PJ: Human babesiosis. N Engl J Med 366:2397, Borne Zoonotic Dis 13:784, 2013.
2012. 280. Weiss LM, Wittner M, Tanowitz HB: The treatment of babesiosis. N
258. Kakoma I, Mehlhorn H: Babesia of domestic animals. In Kreier JP, Engl J Med 344:773, 2001.
editor: Parasitic protozoa (vol 7). ed 2, San Diego, 1994, Academic Press, 281. Ranque S: The treatment of babesiosis. N Engl J Med 344:773, 2001.
p 141. 282. Vannier EG, Diuk-Wasser MA, Ben Mamoun C, et al: Babesiosis. Infect
259. Herwaldt B, Persing DH, Precigout EA, et al: A fatal case of babesiosis Dis Clin North Am 29:357, 2015.
in Missouri: identification of another piroplasm that infects humans. 283. Brasseur P, Gorenflot A: Human babesiosis in Europe. Mem Inst
Ann Intern Med 124:643, 1996. Oswaldo Cruz 87:131, 1992.
260. Bloch EM, Herwaldt BL, Leiby DA, et al: The third described case of 284. Schwartz J, Padmanabhan A, Aqui N, et al: Guidelines on the use
transfusion-transmitted Babesia duncani. Transfusion 52:1517, 2012. of therapeutic apheresis in clinical practice—evidence-based approach
261. Blum S, Gattringer R, Haschke E, et al: The case: hemolysis and acute from the Writing Committee of the American Society for Apheresis:
renal failure. Kidney Int 80:681, 2011. the Seventh Special Issue. J Clin Apher 31:149, 2016.
262. Jiang JF, Zheng YC, Jiang RR, et al: Epidemiological, clinical, and 285. Gubernot DM, Lucey CT, Lee KC, et al: Babesia infection through
laboratory characteristics of 48 cases of “Babesia venatorum” infection blood transfusions: reports received by the US Food and Drug Admin-
in China: a descriptive study. Lancet Infect Dis 15:196, 2015. istration, 1997–2007. Clin Infect Dis 48:25, 2009.
263. Steketee RW, Eckman MR, Burgess EC, et al: Babesiosis in Wisconsin: 286. Leiby DA: Transfusion-transmitted Babesia spp.: bull’s-eye on Babesia
a new focus of disease transmission. JAMA 253:2675, 1985. microti. Clin Microbiol Rev 24:14, 2011.
264. Meldrum SC, Birkhead GS, White DJ, et al: Human babesiosis in New 287. Herwaldt BL, Linden JV, Bosserman E, et al: Transfusion-associated
York State: an epidemiological description of 136 cases. Clin Infect Dis babesiosis in the United States: a description of cases. Ann Intern Med
15:1019, 1992. 155:509, 2011.
265. Hatcher JC, Greenberg PD, Antique J, et al: Severe babesiosis in Long 288. Johnson ST, Cable RG, Tonnetti L, et al: Seroprevalence of Babesia
Island: review of 34 cases and their complications. Clin Infect Dis microti in blood donors from Babesia-endemic areas of the northeastern
32:1117, 2001. United States: 2000 through 2007. Transfusion 49:2574, 2009.